Literature DB >> 24291288

Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.

B Murphy1, C Hillman2, S McDonnel2.   

Abstract

Feline immunodeficiency virus (FIV)-infected cats enter a clinically asymptomatic phase during chronic infection. Despite the lack of overt clinical disease, the asymptomatic phase is characterized by persistent immunologic impairment. In the peripheral blood obtained from cats experimentally infected with FIV-C for approximately 5 years, we identified a persistent inversion of the CD4/CD8 ratio. We cloned and sequenced the FIV-C long terminal repeat containing the viral promoter from cells infected with the inoculating virus and from in vivo-derived peripheral blood mononuclear cells and CD4 T cells isolated at multiple time points throughout the asymptomatic phase. Relative to the inoculating virus, viral sequences amplified from cells isolated from all of the infected animals demonstrated multiple single nucleotide mutations and a short deletion within the viral U3, R and U5 regions. A transcriptionally inactivating proviral mutation in the U3 promoter AP-1 site was identified at multiple time points from all of the infected animals but not within cell-associated viral RNA. In contrast, no mutations were identified within the sequence of the viral dUTPase gene amplified from PBMC isolated at approximately 5 years post-infection relative to the inoculating sequence. The possible implications of these mutations to viral pathogenesis are discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FIV; Feline immunodeficiency virus; LTR; Latency; Lentivirus; Promoter

Mesh:

Year:  2013        PMID: 24291288      PMCID: PMC4038716          DOI: 10.1016/j.virusres.2013.11.017

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  31 in total

1.  Alterations in HIV-1 LTR promoter activity during AIDS progression.

Authors:  Kirsten Hiebenthal-Millow; Thomas C Greenough; Doreen B Bretttler; Michael Schindler; Steffen Wildum; John L Sullivan; Frank Kirchhoff
Journal:  Virology       Date:  2003-12-05       Impact factor: 3.616

Review 2.  Clinical overview of feline immunodeficiency virus.

Authors:  N C Pedersen; J E Barlough
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

3.  Flow cytometric analysis of T-lymphocyte subsets in cats.

Authors:  G A Dean; S L Quackenbush; C D Ackley; M D Cooper; E A Hoover
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

4.  Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections.

Authors:  J E Barlough; C D Ackley; J W George; N Levy; R Acevedo; P F Moore; B A Rideout; M D Cooper; N C Pedersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

5.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.

Authors:  L Bigornia; K M Lockridge; E E Sparger
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation.

Authors:  Anjali Joshi; Thomas W Vahlenkamp; Himanshu Garg; Wayne A F Tompkins; Mary B Tompkins
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

8.  Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change.

Authors:  M A Rigby; E C Holmes; M Pistello; A Mackay; A J Brown; J C Neil
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

9.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 10.  Transmission and immunopathogenesis of FIV in cats as a model for HIV.

Authors:  Mary Jo Burkhard; Gregg A Dean
Journal:  Curr HIV Res       Date:  2003-01       Impact factor: 1.581

View more
  5 in total

1.  Peripheral and central immune cell reservoirs in tissues from asymptomatic cats chronically infected with feline immunodeficiency virus.

Authors:  C D Eckstrand; E E Sparger; K A Pitt; B G Murphy
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

2.  An RNA-Directed Gene Editing Strategy for Attenuating the Infectious Potential of Feline Immunodeficiency Virus-Infected Cells: A Proof of Concept.

Authors:  Brian G Murphy; Tatiana Wolf; Helena Vogel; Diego Castillo; Kevin Woolard
Journal:  Viruses       Date:  2020-05-05       Impact factor: 5.048

3.  Multiple, Independent T Cell Lymphomas Arising in an Experimentally FIV-Infected Cat during the Terminal Stage of Infection.

Authors:  Brian G Murphy; Christina Eckstrand; Diego Castillo; Andre Poon; Molly Liepnieks; Kristy Harmon; Peter Moore
Journal:  Viruses       Date:  2018-05-24       Impact factor: 5.048

4.  Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.

Authors:  C D Eckstrand; C Hillman; A L Smith; E E Sparger; B G Murphy
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

5.  Sequence Instability in the Proviral Long Terminal Repeat and gag Regions from Peripheral Blood and Tissue-Derived Leukocytes of FIV-Infected Cats during the Late Asymptomatic Phase.

Authors:  Christina D Eckstrand; Chadwick Hillman; Brian G Murphy
Journal:  Vet Sci       Date:  2016-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.